Thursday, June 21, 2007

Swiss back cervical cancer shot, UK decision soon

Via Reuters:

Switzerland has recommended that girls should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck & Co Inc (MRK.N: Quote, Profile, Research) and Sanofi-Aventis SA (SASY.PA: Quote, Profile, Research) in Europe, the firms said on Monday.

The Swiss decision to offer the vaccine routinely to 11 to 14-year old girls follows similar moves by Austria, Germany, Italy, France, Norway, Luxembourg and Belgium.

Britain's Joint Committee on Vaccination and Immunisation, meanwhile, will decide on its policy at a meeting on June 20, a spokeswoman for the Department of Health said.

International, Sexually Transmitted Disease | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Swiss back cervical cancer shot, UK decision soon: